1 |
BW Neville et al: Oral and maxillofacial pathology (ed 1). W.B.Saunders, 1995, p 369
|
2 |
Krandorf MJ: Benign soft tissue tumors in a alrge referral population: distribution of specific diagnoses by age, sex, and location. AJR 1995;164:395-402
DOI
ScienceOn
|
3 |
Fasching MC, Slaeh J, Woods JE: Desmoid tumors of the head and neck. Am J Sug 1988;156:327-31
DOI
ScienceOn
|
4 |
Lipschultz A, Maas M: Progesterone treatment of uterine and other abdominal fibroids induced in guinea pigs by alpha estradiol. Cancer Res 1944;4:18-23
|
5 |
Posner MC, Shiu MH, Newsome JL, et al. The desmoid tumor not a benign disease. Arch Surg 1989;124:191-6
DOI
ScienceOn
|
6 |
Siegel NS, Braford CR: Fibromatosis of the head and neck: A challenging lesion. Otolaryngol Head Neck Surg 2000;123:269-75
DOI
ScienceOn
|
7 |
Palman C, Bowen-Pope DF, Broofs JJ: Platelet-derived growthfactor receptors (beta-subunit) immunoreactivity in soft tissue tumors. Lab Ivest 1992;66:108-115
|
8 |
Batsakis JG: Tumors of the head and neck (ed 2). Williams & Wilkins, 1979
|
9 |
Mackenzie DH: The fibromatoses: a clinicopathological concept. BMJ 1972;IV:277-281
DOI
|
10 |
Schmitt G, Mills EE, Levin V, Smit BJ, Borcker H, Pape H: Radiotherapy of aggressive fibromatosis. Eur J Cancer 1922;28A:832-835
|
11 |
Sciarra F: Anti-estrogens and aromatase inhibitors: tamoxifen and testolactone. J Endocrinol Invest 1988;11:755-62
DOI
|
12 |
Brige JA, Sreekantaiah C, Mouron B, Neff JR, Sandberg AA, Wolman SR: Clonal chromosomal abnormalities in desmoid tumors. Implications for histopathogenesis. Cancer 1992;69:430-436
DOI
ScienceOn
|
13 |
Santis DD: Fibromatosis of the mandible: case report and review of previous publications. B J Oral and Maxillofac Surg 1998;36:384-388
DOI
ScienceOn
|
14 |
Lanari A: Effect of progesterone on desmoid tumors. N Engl med 1983;309:123-32
DOI
ScienceOn
|
15 |
Waddell WR, Kirsch WM: Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors. Am J Surg 1991;161:416-21
DOI
ScienceOn
|